Patients with AML or MDS have a higher risk of death if they are hospitalized for COVID-19 than if they are hospitalized for other reasons, data suggest.

Phase 2 data show about half of patients with high-risk or secondary acute myeloid leukemia achieved a complete response or ...

LBS-007, a novel targeted therapy, has received FDA fast track designation for the treatment of acute myeloid leukemia.

Alicia Fivecoat was diagnosed with breast cancer, while her granddaughter Whitney is dealing with acute myeloid leukemia ...

Breeze Hunter's TikTok shows off the MD Anderson room she decorated like a college dorm amid her cancer treatment.

Japan-based Kyowa Kirin is fronting $330 million and pledging up to $1.1 billion in milestones to split the U.S. profits of ...

High cumulative doses of epipodophyllotoxins were associated with the highest risk for survivors of childhood cancer of ...

Cellectis has deprioritized one of its leukemia-focused candidates in order to focus on its other two clinical-stage CAR-T therapies ... relapsed or refractory acute myeloid leukemia.

AUGMENT-101 is a Phase 1/2 trial designed to evaluate revumenib in patients with acute lymphoid leukemia (ALL) and AML, with its Phase 2 portion involving those with relapsed or refractory mNPM1 ...